From 3M’s expanded 510(k) clearance for its Tegaderm dressing to Medtronic and Acacia burying the hatchet, here are 7 medtech stories we missed this week but thought were still worth mentioning.
1. InspireMD inks Taiwanese distro deal for CGuard
InspireMD announced in a June 8 press release that it has signed a distribution deal with Lorion Enterprises. The deal will expand InspireMD’s global footprint and distribute its CGuard Embolic Prevention System (EPS) through the medical device distributor in Taiwan.
2. Active Implants launches NUsurface knee trial
Active Implants announced that it has started its Safety Using NUsurface (SUN) trial in San Diego, according to a June 7 press release. The purpose of the clinical trial is to test the NUsurface Meniscus Implant that is designed to treat persistent knee pain from injured or deteriorating meniscus cartilage. The SUN study will enroll about 120 patients to gain approval from the FDA to be able to sell the device in the U.S.
3. Medtronic and Acacia bury the hatchet
Acacia Research Corp. announced in a June 6 press release that it has entered a license agreement with Medtronic and Medtronic Vascular that covers patents for surgical devices. The license agreement resolves a pending litigation in the U.S. District Court for the District of Delaware.